How Targeted Data Verification Reduces Risk In DCTs

Imagine your decentralized clinical trial (DCT) is over budget, under-enrolled— and you need to change your data monitoring platform. Worse, the trial is producing a continuous stream of disaggregated data. A clinical research organization (CRO) recently approached Remarque Systems for help with precisely this problem.

Our goal was to enable the CRO to reduce the time-and by extension the cost—spent on data verification, allowing them to swiftly uncover anomalies so that the study team could take quick action to reduce risk and improve patient safety. We responded with a combination of consulting and technology.

By centralizing all data, then harnessing expertise to identify the most pertinent data, we were able to support the logistical challenges of changing data management platforms and examine the data in a more cost-effective and actionable way.